Last updated on May 2013

Outcome and Treatment Quality Study of Tolvaptan to Treat Hyponatremia in Patients With Heart Failure.

Brief description of study

The objective is to evaluate the efficacy and safety on the tolvaptan for increasing serum Na levels in patients with worsening heart failure and hyponatremia.

Detailed Study Description

This is a phase 4, multicenter, randomized, double-blind, placebo-controlled, parallel-group interventional study comparing tolvaptan (15 to 60 mg) to placebo in adult patients hospitalized (or admission to emergency room) due to worsening of heart failure and dilutional hyponatremia. All patients will be on standard therapy for heart failure.

Clinical Study Identifier: NCT01865214

Contact Investigators or Research Sites near you

Start Over

Dong Ju Choi, Doctor

Seoul National University Bundang Hospital
Seongnam-si, Korea, Republic of
  Connect »